Achilles Therapeutics ADR (NASDAQ:ACHL)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ACHL

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ACHL

  • Market Cap$469.990m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS00449L1026

Company Profile

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Latest ACHL news

Currently there for this company. Visit our news hub for other news .